3 active warrant series covering 6,859,553 shares (~2.4% potential dilution); nearest expiry 2027-02-28.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.28 | Feb 28, 2027 151d | 187K | ITM | 0.1% | C$52K | Auto |
| warrant | $0.28 | Feb 28, 2027 151d | 5.8M | ITM | 2.0% | C$1.6M | Auto |
| finder | $0.32 | Jul 31, 2027 304d | 888K | ITM | 0.3% | C$284K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 6,170,000 shares (~2.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.10 | Sep 13, 2027 348d | 800K | ITM | 0.3% | C$80K | Auto |
| option | $0.11 | Oct 13, 2028 744d | 1.2M | ITM | 0.4% | C$128K | Auto |
| option | $0.19 | Nov 1, 2029 1128d | 1.4M | ITM | 0.5% | C$258K | Auto |
| option | $0.19 | Nov 4, 2029 1131d | 150K | ITM | 0.1% | C$29K | Auto |
| option | $0.21 | Feb 14, 2030 1233d | 250K | ITM | 0.1% | C$54K | Auto |
| option | $0.63 | Dec 17, 2030 1539d | 2.5M | ITM | 0.9% | C$1.5M | Auto |
282,357,711 shares outstanding, plus 6,859,553 from warrants and 6,170,000 from options — a fully diluted 295,387,264 shares, or ~4.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 6,859,553 shares (~2.4% potential dilution); nearest expiry 2027-02-28.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| finder | $0.28 | Feb 28, 2027 151d | 187K | ITM | 0.1% | C$52K | Auto |
| warrant | $0.28 | Feb 28, 2027 151d | 5.8M | ITM | 2.0% | C$1.6M | Auto |
| finder | $0.32 | Jul 31, 2027 304d | 888K | ITM | 0.3% | C$284K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 6,170,000 shares (~2.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.10 | Sep 13, 2027 348d | 800K | ITM | 0.3% | C$80K | Auto |
| option | $0.11 | Oct 13, 2028 744d | 1.2M | ITM | 0.4% | C$128K | Auto |
| option | $0.19 | Nov 1, 2029 1128d | 1.4M | ITM | 0.5% | C$258K | Auto |
| option | $0.19 | Nov 4, 2029 1131d | 150K | ITM | 0.1% | C$29K | Auto |
| option | $0.21 | Feb 14, 2030 1233d | 250K | ITM | 0.1% | C$54K | Auto |
| option | $0.63 | Dec 17, 2030 1539d | 2.5M | ITM | 0.9% | C$1.5M | Auto |
282,357,711 shares outstanding, plus 6,859,553 from warrants and 6,170,000 from options — a fully diluted 295,387,264 shares, or ~4.6% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
